Zealand Pharma A/S (CPH:ZEAL)
Denmark flag Denmark · Delayed Price · Currency is DKK
312.90
-4.10 (-1.29%)
Aug 28, 2026, 4:59 PM CET

Zealand Pharma Cash Flow Statement

Millions DKK. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
2,7416,455-1,079-703.74-1,202-1,018
Depreciation & Amortization
31.0124.0123.1220.12101.5727.82
Other Amortization
22.3820.3816.491.21.34-
Asset Writedown & Restructuring Costs
---4.71-0.76.52
Stock-Based Compensation
133.89115.8987.0361.4352.2953.5
Other Operating Activities
-686.08-171.08-96.39138.5181.67-130.47
Change in Accounts Receivable
-3,466-88.26-48.96-6.7626.64-64.49
Change in Inventory
10.710.7-2.769.3418.22-52.77
Change in Accounts Payable
-289.34-178.3489.9239.8421.55-49.06
Change in Income Taxes
98.06546.06-4.62---
Change in Other Net Operating Assets
-348.43-202.4384.199.68-56.25-
Operating Cash Flow
-1,7536,532-930.82-425.67-942.31-1,212
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-43.37-33.37-10.05-11.24-11.71-22.13
Sale (Purchase) of Intangibles
-34.71-35.71-3.1-12.51--
Investment in Securities
-1,043-2,179-7,293-1,070186.58-
Other Investing Activities
----106.394.01
Investing Cash Flow
-1,122-2,249-7,307-1,094281.26-18.12

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--369.87--647.91
Long-Term Debt Repaid
--20.16-16.44-543.43-449.81-14.72
Net Debt Issued (Repaid)
-28.16-20.16353.43-543.43-449.81633.19
Issuance of Common Stock
31.1549.158,5231,5641,085775.05
Repurchase of Common Stock
-513.17-407.17-351.83-41.6--28.59
Other Financing Activities
---236.58-71.91-47.35-46.9
Financing Cash Flow
-510.18-378.188,288907.01587.51,333

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
178.26-54.746.23-7.2413.6866.22
Net Cash Flow
-3,2063,85157.39-619.92-59.87168.88

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-1,7966,499-940.87-436.91-954.02-1,234
Free Cash Flow Growth
------
Free Cash Flow Margin
-38.68%70.52%-1500.80%-127.46%-917.45%-1136.94%
Free Cash Flow Per Share
-25.2690.83-14.16-7.72-20.65-28.79
Levered Free Cash Flow
-2,0644,392-736.41-228.98-384.08-589.73
Unlevered Free Cash Flow
-2,0644,393-728.89-213.78-349.29-587.18

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
25.3322.3324.0325.2534.123.3
Cash Income Tax Paid
567.37567.37-11.16-11.3-9.2841.63
Change in Working Capital
-3,99587.73117.7652.110.16-166.33